How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic

Infections are a major cause of morbidity and mortality in patients with chronic lymphocytic leukemia (CLL). These can be exacerbated by anti-leukemic treatments. In addition, the typical patients with CLL already have fragilities and background risk factors that apply to the general population for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hemasphere
Main Authors: Rossi, Davide, Shadman, Mazyar, Condoluci, Adalgisa, Brown, Jennifer R., Byrd, John C., Gaidano, Gianluca, Hallek, Michael, Hillmen, Peter, Mato, Anthony, Montserrat, Emili, Ghia, Paolo
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2020
Assuntos:
Guideline Article - Expert opinion
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7410019/
https://ncbi.nlm.nih.gov/pubmed/32803132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HS9.0000000000000432
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados